Related Experiment Video
Updated: Feb 13, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
SOX6 is downregulated in osteosarcoma and suppresses the migration, invasion and epithelial-mesenchymal transition
Zheng Wang1, Junjie Li1, Kun Li2
1Department of Hand and Foot Surgery, Changyi People's Hospital, Changyi, Shandong 261300, P.R. China.
Abstract:
Transcription factor SOX6 (SOX6) has been reported to serve essential roles in numerous types of cancers. However, the expression and functions of SOX6 in osteosarcoma (OS) have not been analyzed. In the present study, the patterns of SOX6 expression in OS cell lines and tissues were investigated by reverse transcription‑quantitative polymerase chain reaction and western blotting. The results of the present study revealed that SOX6 was notably downregulated in OS tissues and cell lines. Subsequently, gain‑ and loss‑of‑function studies demonstrated that SOX6 inhibited OS cell migration and invasion. In addition, SOX6 may have suppressed epithelial‑mesenchymal transition via twist‑related protein 1 (TWIST1) modulation. Chromatin immunoprecipitation (ChIP), quantitative ChIP and dual luciferase activity assays were used to confirm the binding of SOX6 to the promoter region of TWIST1. Additionally, colony formation assays and Cell Counting Kit‑8 assays demonstrated that SOX6 suppressed cell proliferation. The findings of the present study indicated that SOX6 serves as a tumor suppressor in OS and may be a potential therapeutic target for OS.
Insights
Transcription factor SOX6 is downregulated in osteosarcoma (OS) and suppresses tumor growth, migration, and invasion. This study identifies SOX6 as a potential therapeutic target for OS.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- Transcription factor SOX6 (SOX6) plays roles in various cancers.
- The expression and function of SOX6 in osteosarcoma (OS) remain uninvestigated.
Purpose of the Study:
- To investigate the expression patterns and functional roles of SOX6 in osteosarcoma.
- To determine if SOX6 acts as a tumor suppressor in OS and explore its therapeutic potential.
Main Methods:
- Reverse transcription-quantitative polymerase chain reaction and western blotting were used to assess SOX6 expression in OS tissues and cell lines.
- Gain- and loss-of-function studies, chromatin immunoprecipitation (ChIP), quantitative ChIP, and dual luciferase activity assays were employed to analyze SOX6's functional impact and molecular mechanisms.
- Colony formation and Cell Counting Kit-8 assays were conducted to evaluate SOX6's effect on cell proliferation.
Main Results:
- SOX6 expression was significantly downregulated in OS tissues and cell lines.
- SOX6 overexpression inhibited OS cell migration and invasion, potentially by suppressing epithelial-mesenchymal transition via modulation of twist-related protein 1 (TWIST1).
- SOX6 was confirmed to bind the promoter region of TWIST1, and SOX6 suppressed osteosarcoma cell proliferation.
Conclusions:
- SOX6 functions as a tumor suppressor in osteosarcoma.
- SOX6 represents a potential therapeutic target for osteosarcoma treatment.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Phase Transitions
Properties of Transition Metals
Cooperative Allosteric Transitions
Negative Regulator Molecules
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...

